456 related articles for article (PubMed ID: 25957621)
21. Clinical implications of novel aspects of biliary pathophysiology.
Marzioni M; Saccomanno S; Candelaresi C; Rychlicki C; Agostinelli L; Trozzi L; De Minicis S; Benedetti A
Dig Liver Dis; 2010 Apr; 42(4):238-44. PubMed ID: 20167547
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in Cholangiopathies.
O'Hara SP; Gradilone SA; Masyuk TV; Tabibian JH; LaRusso NF
Curr Pathobiol Rep; 2014 Sep; 2(3):133-142. PubMed ID: 25097819
[TBL] [Abstract][Full Text] [Related]
23. Isolation and Culturing Primary Chaolangiocytes from Mouse Liver.
Kudira R; Sharma BK; Mullen M; Mohanty SK; Donnelly B; Tiao GM; Miethke A
Bio Protoc; 2021 Oct; 11(20):e4192. PubMed ID: 34761065
[TBL] [Abstract][Full Text] [Related]
24. Regulators of Cholangiocyte Proliferation.
Hall C; Sato K; Wu N; Zhou T; Kyritsi K; Meng F; Glaser S; Alpini G
Gene Expr; 2017 Feb; 17(2):155-171. PubMed ID: 27412505
[TBL] [Abstract][Full Text] [Related]
25. The defects of cholangiocyte primary cilia in patients with graft cholangiopathies.
Lu HW; Dong JH; Li CH; Yu Q; Tang W
Clin Transplant; 2014 Oct; 28(10):1202-8. PubMed ID: 25319607
[TBL] [Abstract][Full Text] [Related]
26. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
Trussoni CE; O'Hara SP; LaRusso NF
Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
[TBL] [Abstract][Full Text] [Related]
27. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
Giordano DM; Pinto C; Maroni L; Benedetti A; Marzioni M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275402
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
30. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
31. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
Celli A; Que FG
Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
[TBL] [Abstract][Full Text] [Related]
33. Animal models of cholestasis: An update on inflammatory cholangiopathies.
Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
[TBL] [Abstract][Full Text] [Related]
34. Autophagy and senescence in fibrosing cholangiopathies.
Nakanuma Y; Sasaki M; Harada K
J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
[TBL] [Abstract][Full Text] [Related]
35. Cholangiocytes derived from induced pluripotent stem cells for disease modeling.
Ghanekar A; Kamath BM
Curr Opin Gastroenterol; 2016 May; 32(3):210-5. PubMed ID: 27054776
[TBL] [Abstract][Full Text] [Related]
36. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
37. Morphological aspects of small-duct cholangiopathies: A minireview.
Sticova E; Fabian O
World J Hepatol; 2023 Apr; 15(4):538-553. PubMed ID: 37206655
[TBL] [Abstract][Full Text] [Related]
38. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Pellat A; Vaquero J; Fouassier L
Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
[TBL] [Abstract][Full Text] [Related]
39. Role of Immune Cells in Biliary Repair.
Lan T; Qian S; Tang C; Gao J
Front Immunol; 2022; 13():866040. PubMed ID: 35432349
[TBL] [Abstract][Full Text] [Related]
40. Large-duct cholangiopathies: aetiology, diagnosis and treatment.
Menon S; Holt A
Frontline Gastroenterol; 2019 Jul; 10(3):284-291. PubMed ID: 31288256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
